Announced Sat, 20 Jun · 17:06 IST
Trading Window Closure Ahead of Q1 FY27 Results
Compliance View source PDF
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Price reaction · full curve 14 horizons · vs prior close
-5.4%1-day move
₹3.16
prior close
₹3.10
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
+3.2+3.2+3.2+2.9-5.4-4.1-4.1-0.6-4.7-3.8-6.6-6.3——
Up moveDown movePending
AI summary
Transgene Biotek has closed its trading window for insiders and designated persons from July 1, 2026, until 48 hours after the declaration of unaudited Q1 FY27 financial results for the quarter ended June 30, 2026. The board meeting date to approve these results will be announced separately. This is a routine SEBI compliance measure under the Prohibition of Insider Trading Regulations, 2015.
Likely market impact
Routine regulatory compliance. Insiders barred from trading until 48 hours after Q1 results. No direct impact on retail investors.